Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CSJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CSJKen Fisher 2015-12-31 Reduce$104.41 - $105.42
($104.98)
$ 104.72-0%Reduce -2.23%33,999
CSJKen Fisher 2015-09-30 Reduce$104.82 - $105.36
($105.08)
$ 104.72-0%Reduce -9.53%34,776
CSJKen Fisher 2015-06-30 Reduce$105.07 - $105.72
($105.43)
$ 104.72-1%Reduce -8.59%38,441
CSJKen Fisher 2015-03-31 Reduce$105.11 - $105.58
($105.32)
$ 104.72-1%Reduce -5.61%42,055
CSJJohn Keeley 2013-03-31 Add0.02%$105.36 - $105.74
($105.59)
$ 104.72-1%Add 97.99%14,750
CSJJohn Keeley 2011-12-31 Add0.01%$103.43 - $104.72
($104.12)
$ 104.721%Add 60.82%7,800
CSJKen Fisher 2011-03-31 Add0.01%$104.2 - $104.94
($104.54)
$ 104.720%Add 22.77%216,638
CSJJohn Keeley 2011-03-31 Add$104.2 - $104.94
($104.54)
$ 104.720%Add 24.62%4,050
CSJJohn Keeley 2010-12-31 Add$104.04 - $105.24
($104.73)
$ 104.72-0%Add 35.42%3,250
CSJKen Fisher 2010-09-30 Add0.02%$104.07 - $105.22
($104.71)
$ 104.720%Add 64.68%147,257
CSJKen Fisher 2010-03-31 Add0.01%$103.96 - $104.68
($104.4)
$ 104.720%Add 22.93%80,600
CSJJohn Keeley 2009-09-30 Buy $102.97 - $104.5
($103.96)
$ 104.721%New holding2,650
CSJKen Fisher 2009-03-31 Reduce-0.03%$96.89 - $101.03
($99.4)
$ 104.725%Reduce -87.25%51,910
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CSJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CSJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hibbard, Ingrid Jo-AnnDirector 2016-02-08Sell25,000$20.72405.41view
Metail, Jean FrancoisSenior Officer 2016-02-08Sell35,000$20.83402.74view
Taylor, Larry DouglasDirector 2016-02-08Buy70,000$0.1104620view
Seemann, HaraldDirector 2016-02-08Sell10,000$0.617353.33view
Seemann, HaraldDirector 2016-02-08Buy4,000$0.3827457.89view
Seemann, HaraldDirector 2016-02-08Buy4,000$0.426080view
Eskelund-Hansen, JensDirector, Senior Officer 2016-02-08Buy45,000$0.04261700view
DEISLEY, DAVID LEESenior Officer 2016-02-08Sell97,795$6.351549.13view
Jones, III, Mark E.Director 2016-02-08Buy5,500$0.1761500view
WRIGHT, JOHN DAVIDDirector 2016-02-08Buy40,000$0.3232625view

Quarterly/Annual Reports about CSJ:

    News about CSJ:

    Articles On GuruFocus.com

    More From Other Websites
    Paul Singer says this is the next “Big Short” Jan 01 2016
    Research & Development Investor Briefing Dec 14 2015
    Corporate Bond ETF Ideas For A Rising Rate Environment Dec 08 2015
    ETFs That Can Help You Rebalance if Interest Rates Rise Nov 12 2015
    CSL brands world’s no. 2 influenza vaccine provider as Seqirus Nov 08 2015
    CSL Welcomes New Lifetime Immunisation Register Oct 15 2015
    CSL announces record A$1 billion share buyback Oct 14 2015
    New CHF400 Million & USD100 Million US Private Placement Oct 08 2015
    CSL Names David Lamont as Chief Financial Officer Oct 08 2015
    Is There Any Place to Hide from Market Turmoil? Sep 08 2015
    Is There Any Place to Hide from Market Turmoil? Sep 08 2015
    CSL standing firm on Enterprise Agreement Offer Sep 07 2015
    Corporate Credit Spreads on the Rise Aug 28 2015
    Strong Full Year Result Aug 11 2015
    CSL completes Novartis influenza vaccine business acquisition Aug 02 2015
    Update on Novartis influenza vaccines acquisition Jul 30 2015
    Some Bond ETFs Still Merit Attention Jun 22 2015
    Investor Warning: Is The Stock Market Too High? Jun 12 2015
    How the Fed screwed up the bond market Jun 11 2015
    Silencing the Roar of the Bond Bear May 14 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK